Rallybio Investor Alert: Merger Investigation Launched

Kahn Swick & Foti, LLC Investigating Proposed Merger of Rallybio Corporation

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Former Louisiana Attorney General Charles C. Foti, Jr. and the law firm of Kahn Swick & Foti, LLC have launched an investigation into the proposed merger of Rallybio Corporation and Candid Therapeutics, Inc. The investigation will examine whether the merger and the process leading to it are fair to Rallybio shareholders.

Why it matters

Mergers and acquisitions can have significant impacts on shareholders, so it is important to ensure that the terms and process of such transactions are fair and equitable. This investigation aims to protect the interests of Rallybio shareholders.

The details

Under the proposed merger, Rallybio shareholders are expected to own approximately 3.65% of the combined company. Kahn Swick & Foti, LLC is seeking to determine whether the merger and the process that led to it are adequate, or whether the merger is fair to Rallybio shareholders.

  • The proposed merger was announced on March 4, 2026.

The players

Kahn Swick & Foti, LLC

A law firm that is investigating the proposed merger of Rallybio Corporation and Candid Therapeutics, Inc. to determine if the terms and process are fair to Rallybio shareholders.

Charles C. Foti, Jr.

The former Attorney General of Louisiana and a partner at Kahn Swick & Foti, LLC.

Rallybio Corporation

A biopharmaceutical company that is the target of the proposed merger with Candid Therapeutics, Inc.

Candid Therapeutics, Inc.

A biopharmaceutical company that is proposing to merge with Rallybio Corporation.

Got photos? Submit your photos here. ›

What they’re saying

“If you would like to discuss your legal rights regarding the proposed transaction, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqcm-rlyb/ to learn more.”

— Lewis S. Kahn, Managing Partner, Kahn Swick & Foti, LLC (Kahn Swick & Foti, LLC)

What’s next

Kahn Swick & Foti, LLC will continue its investigation into the proposed merger to determine if the terms and process are fair to Rallybio shareholders.

The takeaway

Mergers and acquisitions can have significant impacts on shareholders, so it is important that the terms and process of such transactions are thoroughly examined to ensure fairness. This investigation by Kahn Swick & Foti, LLC aims to protect the interests of Rallybio shareholders.